feed,title,long_url,short_url
Benzinga,"FDA Rejects Eli Lilly's Donanemab For Alzheimer's Disease, Needs More Data",https://benzinga.com/general/biotech/23/01/30497466/fda-rejects-eli-lillys-donanemab-for-alzheimers-disease-needs-more-data,https://da.gd/uydk
